KRT14 and Hyperkeratosis: As expected, hyperkeratosis and epidermal hyperplasia were present in PKM2flox/flox mice but subjectively reduced in PKM2flox/flox K14-cre mice after 5 days of topical IMQ treatment (Figure 5C).